Literature DB >> 9588719

Margin of resection in the management of primary melanoma.

N Cascinelli1.   

Abstract

In the last 20 years, it has become evident that the continued use of 4 to 5 cm margins of resection around a primary melanoma is not justified. A prospective randomized trial by the World Health Organization (WHO) Melanoma Group showed that for melanomas up to 2 mm thick, a 1 cm margin provides local control similar to that observed after a 3 cm margin. Another prospective randomized trial by the Melanoma Intergroup Committee in the United States concluded that for melanomas 1 to 4 mm in thickness, a 2 cm margin of resection provides local control that is as good as a 4 cm margin. For melanomas thicker than 4 mm, the current evidence suggests that a 2 cm margin is adequate, the chief manifestation of recurrence for these thick lesions being hematogenous and lymphogenous spread. The adoption of the narrower surgical margins suggested above should reduce the morbidity caused by the radical margins of the past without compromising local control of the disease.

Entities:  

Mesh:

Year:  1998        PMID: 9588719     DOI: 10.1002/(sici)1098-2388(199806)14:4<272::aid-ssu2>3.0.co;2-#

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  11 in total

Review 1.  Melanoma of the head and neck.

Authors:  Terry A Day; Joshua D Hornig; Anand K Sharma; Frank Brescia; M Boyd Gillespie; Deanne Lathers
Journal:  Curr Treat Options Oncol       Date:  2005-01

2.  Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.

Authors:  Travis E Grotz; Svetomir N Markovic; Lori A Erickson; William S Harmsen; Marianne Huebner; David R Farley; Barbara A Pockaj; John H Donohue; Franklin H Sim; Clive S Grant; Sanjay P Bagaria; Thomas C Shives; Charles M Balch; James W Jakub
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

3.  Re-excision within a radius of 2 cm in patients with melanoma of the skin - sufficient for local oncological radicalness.

Authors:  Strahil Asenov Strashilov; Angel Danchev Yordanov; Mariela Borisova Vasileva-Slaveva; Assia Andrianova Konsoulova
Journal:  Arch Med Sci       Date:  2020-07-08       Impact factor: 3.707

4.  Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?

Authors:  Matthew P Doepker; Zachary J Thompson; Kate J Fisher; Maki Yamamoto; Kevin W Nethers; Jennifer N Harb; Matthew A Applebaum; Ricardo J Gonzalez; Amod A Sarnaik; Jane L Messina; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2016-03-08       Impact factor: 5.344

5.  Toward in vivo biopsy of melanoma based on photoacoustic and ultrasound dual imaging with an integrated detector.

Authors:  Yating Wang; Dong Xu; Sihua Yang; Da Xing
Journal:  Biomed Opt Express       Date:  2016-01-05       Impact factor: 3.732

Review 6.  Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.

Authors:  Luiz Guilherme Martins Castro; Maria Cristina Messina; Walter Loureiro; Ricardo Silvestre Macarenco; João Pedreira Duprat Neto; Thais Helena Bello Di Giacomo; Flávia Vasques Bittencourt; Renato Marchiori Bakos; Sérgio Schrader Serpa; Hamilton Ometto Stolf; Gabriel Gontijo
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

7.  Fully Regressive Melanoma: A Case Without Metastasis.

Authors:  Eric Ehrsam; Joseph R Kallini; Damien Lebas; Amor Khachemoune; Philippe Modiano; Hervé Cotten
Journal:  J Clin Aesthet Dermatol       Date:  2016-08-01

8.  New Safety Margins for Melanoma Surgery: Nice Possibility for Drinking of "Just That Cup of Coffee"?

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva
Journal:  Open Access Maced J Med Sci       Date:  2017-06-11

9.  Late-Developing Metastatic Malignant Melanoma in the Thoracic Spine Originating from Choroidal Melanoma.

Authors:  Jun Kyu Hwang; Kyung Hyun Kim; Ji Sup Kim; Sung Jun Ahn; Sung Uk Kuh
Journal:  Korean J Spine       Date:  2017-06-30

10.  Clinical and prognostic factors in 98 patients with malignant melanoma in China.

Authors:  Min Zhang; Nan Zhang
Journal:  J Int Med Res       Date:  2017-06-06       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.